Eli Lilly has issued a warning regarding the shortage of an insulin product in both Canada and the U.S. that is expected to persist until mid-April.
Eli Lilly has issued a warning regarding the shortage of an insulin product in both Canada and the U.S. that is expected to persist until mid-April.